| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner
2 companies
Ross Michael Jay is a Director, 10% Owner at X4 Pharmaceuticals, Inc with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $5.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2017 | XFOR X4 Pharmaceuticals, Inc | Director, 10% Owner | Buy | 500,000 | $10.00 | $5,000,000.00 | +15.5% |